No differences were observed between these two populations regarding other myeloma-related markers (CD38, CD45, CD56) and both subpopulations were negative for the B-cell markers CD19, CD20 and CD27 (Figure 1B). The gene discussed is NCAM1; the disease is plasma cell myeloma.